Global Impressions scale change item (CGI‐I or similar): no. of responders (acute phase) · adults with SAnD
It is very uncertain whether comparison 6: beta‐blockers changes global Impressions scale change item (CGI‐I or similar): no. of… compared with placebo (very low certainty).
1 finding from 1 review
Variation in the decrease in 24‐hour ambulatory hourly SBP (at 3 to 12 weeks) · Men and non‐pregnant women ≥ 18 years old with essential hypertension
1 finding from 1 review
no estimate extracted
121 participants
Very low
Variation in the decrease in 24‐hour ambulatory hourly DBP (at 3 to 12 weeks) · Men and non‐pregnant women ≥ 18 years old with essential hypertension
1 finding from 1 review
no estimate extracted
121 participants
Very low
Variation in the decrease in 24‐hour ambulatory hourly HR (at 3 to 12 weeks) · Men and non‐pregnant women ≥ 18 years old with essential hypertension
1 finding from 1 review
no estimate extracted
71 participants
Very low
All‐cause mortality (30 days)—cardiac surgery · patients with coronary heart disease and/or valvular heart disease
Beta‐blocker showed no clear difference in all‐cause mortality (30 days)—cardiac surgery compared with control—cardiac surgery (moderate certainty).
1 finding from 1 review
Cerebrovascular events—non‐cardiac surgery · patients with conditions requiring non‐cardiac surgery
Beta‐blocker showed no clear difference in cerebrovascular events—non‐cardiac surgery compared with control—non‐cardiac surgery (low certainty).
1 finding from 1 review
Ventricular arrhythmias—non‐cardiac surgery ECG · patients with conditions requiring non‐cardiac surgery
Beta‐blocker showed no clear difference in ventricular arrhythmias—non‐cardiac surgery ECG compared with control—non‐cardiac surgery (moderate certainty).
1 finding from 1 review
All supraventricular arrhythmias—non‐cardiac surgery ECG · patients with conditions requiring non‐cardiac surgery
Beta‐blocker leads to lower all supraventricular arrhythmias—non‐cardiac surgery ECG compared with control—non‐cardiac surgery (high certainty).
1 finding from 1 review
Bradycardia—non‐cardiac surgery ECG · patients with conditions requiring non‐cardiac surgery
Beta‐blocker probably leads to higher bradycardia—non‐cardiac surgery ECG compared with control—non‐cardiac surgery (moderate certainty).
1 finding from 1 review
Hypotension—non‐cardiac surgery · patients with conditions requiring non‐cardiac surgery
Beta‐blocker leads to higher hypotension—non‐cardiac surgery compared with control—non‐cardiac surgery (high certainty).
1 finding from 1 review
Acute myocardial infarction—cardiac surgery · patients with coronary heart disease and/or valvular heart disease
Beta‐blocker showed no clear difference in acute myocardial infarction—cardiac surgery compared with control—cardiac surgery (moderate certainty).
1 finding from 1 review
Cerebrovascular events—cardiac surgery · patients with coronary heart disease and/or valvular heart disease
Beta‐blocker showed no clear difference in cerebrovascular events—cardiac surgery compared with control—cardiac surgery (low certainty).
1 finding from 1 review
Ventricular arrhythmias—cardiac surgery ECG · patients with coronary heart disease and/or valvular heart disease
Beta‐blocker probably leads to lower ventricular arrhythmias—cardiac surgery ECG compared with control—cardiac surgery (moderate certainty).
1 finding from 1 review
All supraventricular arrhythmias—cardiac surgery ECG · patients with coronary heart disease and/or valvular heart disease
Beta‐blocker leads to lower all supraventricular arrhythmias—cardiac surgery ECG compared with control—cardiac surgery (high certainty).
1 finding from 1 review
Bradycardia · patients with coronary heart disease and/or valvular heart disease
Beta‐blocker showed no clear difference in bradycardia—cardiac surgery ECG compared with control—cardiac surgery (low certainty).
1 finding from 1 review
Hypotension—cardiac surgery · patients with coronary heart disease and/or valvular heart disease
Beta‐blocker showed no clear difference in hypotension—cardiac surgery compared with control—cardiac surgery (low certainty).
1 finding from 1 review
All‐cause mortality (30 days)—non‐cardiac surgery · patients with conditions requiring non‐cardiac surgery
Beta‐blocker showed no clear difference in all‐cause mortality (30 days)—non‐cardiac surgery compared with control—non‐cardiac surgery (low certainty).
1 finding from 1 review
Acute myocardial infarction—non‐cardiac surgery · patients with conditions requiring non‐cardiac surgery
Beta‐blocker leads to lower acute myocardial infarction—non‐cardiac surgery compared with control—non‐cardiac surgery (high certainty).
1 finding from 1 review